Hutchmed (China) (00013.HK) announced on June 26th that the company will hold a board meeting on Wednesday, July 31st, 2024 to approve the mid-term performance of the company and its subsidiaries for the six months ending on June 30th, 2024 (including) and release it at 7:00 pm that day (Hong Kong time).
和黄医药(00013.HK)拟7月31日举行董事会会议批准中期业绩
Hutchmed (China) (00013.HK) plans to hold a board of directors meeting on July 31 to approve its mid-term performance.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.